Preferred and Actual Places of Death Among Patients with Advanced Cancer: A Single-centre Cohort Study in Japan

被引:0
作者
Ikari, Tomoo [1 ]
Hiratsuka, Yusuke [1 ]
Oishi, Takayuki [2 ]
Miyashita, Mitsunori [3 ]
Morita, Tatsuya [4 ]
Mack, Jennifer W. [5 ,6 ]
Okada, Yoshinari [2 ]
Chiba, Natsuko [2 ]
Ishioka, Chikashi [7 ]
Inoue, Akira [1 ]
机构
[1] Tohoku Univ, Sch Med, Dept Palliat Med, Sendai, Japan
[2] Tohoku Univ, Inst Dev Aging & Canc, Dept Clin Oncol, Sendai, Japan
[3] Tohoku Univ, Sch Med, Dept Palliat Nursing, Sendai, Japan
[4] Seirei Mikatahara Gen Hosp, Dept Palliat & Support Care, Palliat Care Team, Hamamatsu, Japan
[5] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA USA
[6] Dana Farber Canc Inst, Ctr Populat Sci, Boston, MA USA
[7] Tohoku Univ, Grad Sch Med, Dept Clin Oncol, Sendai, Japan
关键词
Advanced cancer; Preferred place of death; Actual place of death; End-of-life discussion; Chemotherapy; END-OF-LIFE; PALLIATIVE CARE; DETERMINANTS; CHEMOTHERAPY; ASSOCIATIONS; PREDICTORS; DISTRESS; OUTCOMES; LUNG; HOME;
D O I
10.25259/IJPC_133_2024
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives: Achieving a 'good death' is one of the important goals of palliative care. Providing goal-concordant care and an environment tailored to the patient's preferences can contribute to a 'good death'. However, the concordance rate between the preferred and actual places of death among advanced cancer patients in Japan is less explored. This study aimed to identify the concordance between patients' preferred and actual places of death and the associated factors among patients with advanced cancer in Japan. Materials and Methods: Patients with advanced cancer who underwent chemotherapy at Tohoku University Hospital between January 2015 and January 2016 were enrolled and followed up for 5 years. The enrolled patients were asked about their preference for their place of death. The response options were: "Own home," "General ward" and "Palliative care unit (PCU)." We compared the actual place of death with the patient's preference through a followup review of the medical records. Results: A total of 157 patients with advanced cancer were enrolled between January 2015 and January 2016. Of these patients, 22.9% (11/48) died at home according to their preference, 64.0% (16/25) in the general ward and 37.9% (11/29) in the PCU. Only thirty-seven (37.3%) patients died where they wanted, based on the comparison between patients' preferences and actual places of death. Conclusion: The concordance rate between the preferred and actual places of death is not high in Japan. Improving concordance between patients' preferences and actual places of death has the potential to improve end-of-life care.
引用
收藏
页码:268 / 274
页数:7
相关论文
共 34 条
  • [1] Can This Patient Be Discharged Home? Factors Associated With At-Home Death Among Patients With Cancer
    Alonso-Babarro, Alberto
    Bruera, Eduardo
    Varela-Cerdeira, Maria
    Jesus Boya-Cristia, Maria
    Madero, Rosario
    Torres-Vigil, Isabel
    De Castro, Javier
    Gonzalez-Baron, Manuel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (09) : 1159 - 1167
  • [2] Actual and preferred place of death of cancer patients. Results from the Italian survey of the dying of cancer (ISDOC)
    Beccaro, M
    Costantini, M
    Rossi, PG
    Miccinesi, G
    Grimaldi, M
    Bruzzi, P
    [J]. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2006, 60 (05) : 412 - 416
  • [3] Cabinet Office, US
  • [4] International study of the place of death of people with cancer: a population-level comparison of 14 countries across 4 continents using death certificate data
    Cohen, J.
    Pivodic, L.
    Miccinesi, G.
    Onwuteaka-Philipsen, B. D.
    Naylor, W. A.
    Wilson, D. M.
    Loucka, M.
    Csikos, A.
    Pardon, K.
    Van den Block, L.
    Ruiz-Ramos, M.
    Cardenas-Turanzas, M.
    Rhee, Y.
    Aubry, R.
    Hunt, K.
    Teno, J.
    Houttekier, D.
    Deliens, L.
    [J]. BRITISH JOURNAL OF CANCER, 2015, 113 (09) : 1397 - 1404
  • [5] Does place of death from cancer vary between ethnic groups in South East England?
    Coupland, Victoria H.
    Madden, Peter
    Jack, Ruth H.
    Moller, Henrik
    Davies, Elizabeth A.
    [J]. PALLIATIVE MEDICINE, 2011, 25 (04) : 314 - 322
  • [6] Clinical Challenges of Immune Checkpoint Inhibitors
    de Miguel, Maria
    Calvo, Emiliano
    [J]. CANCER CELL, 2020, 38 (03) : 326 - 333
  • [7] Actual and Preferred Place of Death of Home-Dwelling Patients in Four European Countries: Making Sense of Quality Indicators
    De Roo, Maaike L.
    Miccinesi, Guido
    Onwuteaka-Philipsen, Bregje D.
    Van Den Noortgate, Nele
    Van den Block, Lieve
    Bonacchi, Andrea
    Donker, Ge A.
    Alonso, Jose E. Lozano
    Moreels, Sarah
    Deliens, Luc
    Francke, Anneke L.
    [J]. PLOS ONE, 2014, 9 (04):
  • [8] Outcomes of Prognostic Disclosure: Associations With Prognostic Understanding, Distress, and Relationship With Physician Among Patients With Advanced Cancer
    Enzinger, Andrea C.
    Zhang, Baohui
    Schrag, Deborah
    Prigerson, Holly G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (32) : 3809 - +
  • [9] Fayers P, 2002, EUR J CANCER, V38, pS125
  • [10] Determinants of the place of death among terminally ill cancer patients under home hospice care in Japan
    Fukui, S
    Kawagoe, H
    Masako, S
    Noriko, N
    Hiroko, N
    Toshie, M
    [J]. PALLIATIVE MEDICINE, 2003, 17 (05) : 445 - 453